🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
TAK-981 is being tested in combination with anti-CD38 monoclonal antibodies...
Status
Terminated
Location
Mayo Clinic Arizona - PPDS
Start Date
2021-04-20
Trial ID
NCT04776018
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability, maximum...
Status
Completed
Location
City of Hope - Duarte
Start Date
2018-04-20
Trial ID
NCT03439280
Treatments Being Tested
Antibody-mediated rejection (AMR) is a major cause of worsening kidney func...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07613359
Treatments Being Tested
Primary immune thrombocytopenia (ITP) is a condition where the immune syste...
Status
Recruiting
Location
Genesis Cancer and Blood Institute - SCRI
Start Date
2025-08-14
Trial ID
NCT06948318
Treatments Being Tested
Myasthenia gravis is an autoimmune condition that causes muscle weakness. A...
Status
Completed
Location
The University of Arizona Medical Center
Start Date
2020-01-14
Trial ID
NCT04159805
Treatments Being Tested
Primary immune thrombocytopenia (ITP) is a condition where the immune syste...
Status
Recruiting
Location
Genesis Cancer and Blood Institute - SCRI
Start Date
2025-02-27
Trial ID
NCT06722235
Treatments Being Tested
Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when ...
Status
Recruiting
Location
UAB Nephrology Research Clinic at Paula Building
Start Date
2025-07-15
Trial ID
NCT06963827
Treatments Being Tested
This study will have two parts. The main aims are to: * check the side eff...
Status
Completed
Location
Amicis Research Center - Northridge - Nordhoff
Start Date
2022-08-16
Trial ID
NCT05174221
Treatments Being Tested
The purpose of this original study is to determine the recommended phase 2 ...
Status
Completed
Location
Alabama Oncology
Start Date
2019-07-29
Trial ID
NCT03984097
Treatments Being Tested